Neurosurgery Faculty

The goal of this program is to stimulate cross-disciplinary knowledge and research. In the first seminar in this series, Elias Sayour, MD, PhD will be discussing some aspects of COVID-19 vaccine development.

The weekend of Feb. 21-23, Mitchell and the UF brain tumor team he co-leads brought together expert investigators, physician-scientists and passionate supporters from across the U.S. and beyond to form new partnerships and collaborate in pursuit of discovering new immunotherapy regimens to improve quality of life and turn deadly brain cancers into livable diseases within 10 years.

Watch an interview with Dr. Duane Mitchell, the co-director of the ReMission Alliance Against Brain Tumors, explaining how elite brain tumor researchers came together to form the Alliance, the benefits of team science, current treatment options and how research is advancing to provide more hope to those who are diagnosed with cancer, including children.

Duane A. Mitchell, M.D., Ph.D., appointed as director of the UF Clinical and Translational Science Institute, assistant vice president for research, and associate dean for translational science and clinical research.